{"title": "Grippeimpfung: Kritische Beurteilung und praktische Empfehlungen", "author": "PHC Primary; Hospital Care; L\u00e9na Dietrich; Marta Abreu De Azevedo; Sebastian Wirz; Michael J Deml; Lisa Schmid-Thurneysen; J\u00fcrg Fr\u00f6hlich; Romeo Providoli; Thomas Ernst; Muhannad Seyam; Meliha Jusufoska; Josipa Tolic; Clara Zimmermann; Tessa Scafetta; Patrizia Wueger; Simone Weissen; Caesar Gallmann; Philipp Busche; Bernhard Wingeier; Lukas Sch\u00f6b; Domenica Flury; Alexandra R\u00f6llin; Charles B\u00e9guelin; Gisela Etter; Benedikt Huber; Philip Tarr", "url": "https://phc.swisshealthweb.ch/de/article/doi/phc-d.2021.10341/", "hostname": "swisshealthweb.ch", "description": "Die Grippeimpfung gilt allgemein als sicherste, einfachste und wirksamste Methode, um Influenza zu vermeiden. Haus- und Spital\u00e4rzt/-innen und das Pflegepersonal stehen der Grippeimpfung allerdings zum Teil kritisch gegen\u00fcber, was den Nutzen bei \u00e4lteren Personen und bei sich selbst betrifft.", "sitename": "L\u00e9na Dietrich,Marta Abreu De Azevedo,Sebastian Wirz,Michael J. Deml,Lisa Schmid-Thurneysen,J\u00fcrg Fr\u00f6hlich,Romeo Providoli,Thomas Ernst,Muhannad Seyam,Meliha Jusufoska,Josipa Tolic,Clara Zimmermann,Tessa Scafetta,Patrizia Wueger,Simone Weissen,Caesar Gallmann,Philipp Busche,Bernhard Wingeier,Lukas Sch\u00f6b,Domenica Flury,Alexandra R\u00f6llin,Charles B\u00e9guelin,Gisela Etter,Benedikt Huber,Philip Tarr", "date": "2021-02-02", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "1 Dietrich LG, De Abreu Azevedo M, Tarr PE. COVID-19, Influenza, grippe-\u00e4hnliche Erkrankung.\n[https://primary-hospital-care.ch/article/doi/phc-d.2020.10323](https://primary-hospital-care.ch/article/doi/phc-d.2020.10323)\n.\n2 Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect Dis. 2003;37:1094\u2013101.\n3 Paules C, Subbarao K. Influenza. Lancet. 2017;390:697\u2013708.\n4 Gon\u00e7alves AR, Kaiser L. Was steckt hinter der Grippe? Swiss Medical Forum 2019; 19: 181\u20136.\n5 Jenkin DC, Mahgoub H, Morales KF, Lambach P, Nguyen-Van-Tam JS. A rapid evidence appraisal of influenza vaccination in health workers: An important policy in an area of imperfect evidence. Vaccine X 2019;2:100036.\n6 Bundesamt f\u00fcr Gesundheit. Nationale Strategie zur Pr\u00e4vention der saisonalen Grippe (GRIPS) 2015\u20132018 (weiterhin g\u00fcltig bis Ende 2020).\n[https://www.bag.admin.ch/bag/de/home/das-bag/publikationen/broschueren/publikationen-uebertragbare-krankheiten/strategie-grips.html](https://www.bag.admin.ch/bag/de/home/das-bag/publikationen/broschueren/publikationen-uebertragbare-krankheiten/strategie-grips.html)\n(accessed May 6, 2020).\n7 Mereckiene J, European Center for Disease Prevention and Control. Seasonal influenza vaccination and antiviral use in EU/EEA Member States. ECDC Technical Report.\n8 Frey K, Fontana M-C, Itin A. Evaluation der Kommunikationsstrategie zur Pr\u00e4vention der saisonalen Grippe 2008\u20132012. Im Auftrag des Bundesamtes f\u00fcr Gesundheit. 2012; published online Jan 26.\n[https://www.bag.admin.ch/dam/bag/de/dokumente/e-f/evalber-mt/2012-evaluation-saisonale-grippe-2008\u20132012-executive-summary.pdf.download.pdf/2011-excsum-eval-komm-saisonale-grippe-d.pdf](https://www.bag.admin.ch/dam/bag/de/dokumente/e-f/evalber-mt/2012-evaluation-saisonale-grippe-2008-2012-executive-summary.pdf.download.pdf/2011-excsum-eval-komm-saisonale-grippe-d.pdf)\n(accessed June 13, 2020).\n9 Friedl A, Aegerter C, Saner E, Meier D, Beer JH. An intensive 5-year-long influenza vaccination campaign is effective among doctors but not nurses. Infection. 2012;40:57\u201362.\n10 Tapiainen T, B\u00e4r G, Schaad UB, Heininger U. Influenza vaccination among healthcare workers in a university children\u2019s hospital. Infect Control Hosp Epidemiol. 2005;26:855\u20138.\n11 Deml MJ, Jafflin K, Merten S, et al. Determinants of vaccine hesitancy in Switzerland: study protocol of a mixed-methods national research programme. BMJ Open. 2019;9:e032218.\n12 Deml MJ, Notter J, Kliem P, et al. \u201cWe treat humans, not herds!\u201d: A qualitative study of complementary and alternative medicine (CAM) providers\u2019 individualized approaches to vaccination in Switzerland. Soc Sci Med. 2019;240:112556.\n13 Osterholm MT, Kelley NS, Manske JM. The Compelling need for game-chaning influneza vaccines. Center for Infectious Disease Research and Policy. 2012; published online Oct.\n[https://www.cidrap.umn.edu/compelling-need-game-changing-influenza-vaccines](https://www.cidrap.umn.edu/compelling-need-game-changing-influenza-vaccines)\n(accessed May 30, 2020).\n14 Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. The Lancet Infectious Diseases. 2012;12:36\u201344.\n16 Jaberg S. Flu vaccines divide medical community. 2012; published online Nov 2. https://www.swissinfo.ch/eng/struggling-health-campaign_flu-vaccines-divide-medical-community/33843824 (accessed May 29, 2020).\n19 Center for Disease Control and Prevention. Influenza (Flu) How Well Flu Vaccines Work.\n[https://www.cdc.gov/flu/vaccines-work/vaccineeffect.htm](https://www.cdc.gov/flu/vaccines-work/vaccineeffect.htm)\n(accessed June 17, 2020).\n20 Fireman B, et al. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol. 2009;170(5):650\u20136.\n21 Demicheli V, Jefferson T, Di Pietrantonj C, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2018;2:CD004876.\n22 R\u00f6llin A. Impfungen nach dem S\u00e4uglingsalter. Pharmakritik. In press.\n23 Thomas RE. Is influenza-like illness a useful concept and an appropriate test of influenza vaccine effectiveness? Vaccine. 2014;32:2143\u20139.\n24 Demicheli V, Jefferson T, Ferroni E, Rivetti A, Di Pietrantonj C. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2018;2:CD001269.\n25 Rondy M, Kissling E, Emborg H-D, et al. Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies. Euro Surveill. 2018;23:21187\u201321.\n26 Flannery B, Kondor RJG, Chung JR, et al. Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018\u20132019 Season. J Infect Dis. 2020;221:8\u201315.\n27 Atmar RL, Keitel WA. Searching for Improved Flu Vaccines-The Time Is Now. J Infect Dis. 2020;221:1\u20134.\n28 Bitterman R, Eliakim-Raz N, Vinograd I, Zalmanovici Trestioreanu A, Leibovici L, Paul M. Influenza vaccines in immunosuppressed adults with cancer. Cochrane Database Syst Rev 2018;2:CD008983.\n29 Mertz D, Kim TH, Johnstone J, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347:f5061\u20131.\n30 Goeijenbier M, van Sloten TT, Slobbe L, et al. Benefits of flu vaccination for persons with diabetes mellitus: A review. Vaccine. 2017;35:5095\u2013101.\n31 Mart\u00ednez-Baz I, Navascu\u00e9s A, Portillo ME, et al. Effect of influenza vaccination in preventing laboratory-confirmed influenza hospitalization in patients with diabetes mellitus. Clin Infect Dis 2020; published online May 15. DOI:10.1093/cid/ciaa564.\n32 Modin D, J\u00f8rgensen ME, Gislason G, et al. Influenza Vaccine in Heart Failure. Circulation. 2019;139:575\u201386.\n33 Vardeny O, Solomon SD. Influenza and Heart Failure: A Catchy Comorbid Combination. JACC Heart Fail. 2019;7:118\u201320.\n34 Vardeny O, Claggett B, Udell JA, et al. Influenza Vaccination in Patients With Chronic Heart Failure: The PARADIGM-HF Trial. JACC Heart Fail. 2016;4:152\u20138.\n35 Modin D, Clagetti B, Joergensen M, Koeber L. The flu vaccine and mortality in hypertension. A Danish nationwide cohort study. Eur Heart J. 2019;1347.\n36 Acharya D, Uyeki TM. The PARADIGM of Influenza Vaccination in Heart Failure Patients. JACC Heart Fail. 2016;4:159\u201361.\n37 DeVore AD, Bhatt AS. Influenza Vaccination in Patients With Heart Failure. Circulation. 2019;139:587\u20139.\n38 Kopsaftis Z, Wood-Baker R, Poole P. Influenza vaccine for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev 2018;6:CD002733.\n40 Mertz D, Fadel SA, Lam P-P, et al. Herd effect from influenza vaccination in non-healthcare settings: a systematic review of randomised controlled trials and observational studies. Euro Surveill. 2016;21:687.\n41 Rasmussen SA, Jamieson DJ, Bresee JS. Pandemic influenza and pregnant women. Emerging Infect Dis. 2008;14:95\u2013100.\n42 Swamy GK, Heine RP. Vaccinations for pregnant women. Obstetrics & Gynecology. 2015;125:212\u201326.\n43 Madhi SA, Cutland CL, Kuwanda L, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014;371:918\u201331.\n44 Steinhoff MC, Omer SB. A review of fetal and infant protection associated with antenatal influenza immunization. Am J Obstet Gynecol. 2012;207:S21\u20137.\n45 Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359:1555\u201364.\n46 Omer SB. Maternal Immunization. N Engl J Med. 2017;376:1256\u201367.\n47 Gall SA, Poland GA. A maternal immunization program (MIP): developing a schedule and platform for routine immunization during pregnancy. Vaccine. 2011;29:9411\u20133.\n48 Fell DB, Platt RW, Lanes A, et al. Fetal death and preterm birth associated with maternal influenza vaccination: systematic review. BJOG. 2015;122:17\u201326.\n49 Bratton KN, Wardle MT, Orenstein WA, Omer SB. Maternal influenza immunization and birth outcomes of stillbirth and spontaneous abortion: a systematic review and meta-analysis. Clin Infect Dis. 2015;60:e11\u20139.\n50 McMillan M, Porritt K, Kralik D, Costi L, Marshall H. Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine. 2015;33:2108\u201317.\n51 Giles ML, Krishnaswamy S, Macartney K, Cheng A. The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review. Hum Vaccin Immunother. 2019;15:687\u201399.\n52 Donzelli A. Influenza vaccination for all pregnant women? So far the less biased evidence does not favour it. Hum Vaccin Immunother. 2019;15:2159\u201364.\n53 Donzelli A. Influenza vaccination in pregnancy: careful assessment confirms safety concerns for the offspring. Hum Vaccin Immunother. 2019;15:2168\u201370.\n54 Fell DB, Omer SB, Edwards KM. Influenza immunization during pregnancy: toward a balanced assessment of safety evidence. Hum Vaccin Immunother. 2019;15:2165\u20137.\n55 Lindsey B, Kampmann B, Jones C. Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants. Curr Opin Infect Dis. 2013;26:248\u201353.\n56 Glezen WP. Effect of maternal antibodies on the infant immune response. Vaccine. 2003;21:3389\u201392.\n57 Jackson LA, Patel SM, Swamy GK, et al. Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis. 2011;204:854\u201363.\n58 Steinhoff MC, Omer SB, Roy E, et al. Influenza immunization in pregnancy \u2013 antibody responses in mothers and infants. N Engl J Med. 2010;362:1644\u20136.\n59 Walker JL, Zhao H, Dabrera G, et al. Assessment of Effectiveness of Seasonal Influenza Vaccination During Pregnancy in Preventing Influenza Infection in Infants in England, 2013\u20132014 and 2014\u20132015. J Infect Dis. 2020;221:16\u201320.\n60 Cohen C, Nunes MC. Vaccinating Mothers to Protect Their Babies Against Influenza. J Infect Dis. 2020;221:5\u20137.\n61 Omer SB, Zaman K, Roy E, et al. Combined effects of antenatal receipt of influenza vaccine by mothers and pneumococcal conjugate vaccine receipt by infants: results from a randomized, blinded, controlled trial. J Infect Dis. 2013;207:1144\u20137.\n62 Anderson ML, Dobkin C, Gorry D. The Effect of Influenza Vaccination for the Elderly on Hospitalization and Mortality: An Observational Study With a Regression Discontinuity Design. Ann Intern Med. 2020;172:445\u201352.\n63 Puhan D, Huber F, Sol\u00e8r R. Kommentar zum Schweizerischen Impfplan 2018. 2018; published online July.\n[https://www.medix.ch/media/factsheet_impfungen_2018.pdf](https://www.medix.ch/media/factsheet_impfungen_2018.pdf)\n(accessed June 13, 2020).\n64 Schanzer DL, Langley JM, Tam TWS. Co-morbidities associated with influenza-attributed mortality, 1994\u20132000, Canada. Vaccine 2008;26:4697\u2013703.\n65 Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. The Lancet Infectious Diseases. 2009;9:601\u201310.\n66 Musher DM, Rueda AM, Kaka AS, Mapara SM. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis. 2007;45:158\u201365.\n67 Cangemi R, Casciaro M, Rossi E, et al. Platelet activation is associated with myocardial infarction in patients with pneumonia. J Am Coll Cardiol. 2014;64:1917\u201325.\n68 Corrales-Medina VF, Suh KN, Rose G, et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med 2011;8:e1001048.\n69 Eurich DT, Marrie TJ, Minhas-Sandhu JK, Majumdar SR. Risk of heart failure after community acquired pneumonia: prospective controlled study with 10 years of follow-up. BMJ. 2017;356:j413.\n70 Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation. 2012;125:773\u201381.\n71 Corrales-Medina VF, Alvarez KN, Weissfeld LA, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA. 2015;313:264\u201374.\n72 Betsch C, Hirschhausen von E, Zlka-Menhorn V. Impfberatung in der Praxis: Professionelle Gespr\u00e4chsf\u00fchrung \u2013 wenn Reden Gold wert ist. Dtsch Arztebl. 2019; 116: A\u2013520\u2013B\u2013427\u2013C\u2013422.\n73 Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K. Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev 2015; 28: CD005050.\n74 Caldeira D, Ferreira JJ, Costa J. Influenza vaccination and prevention of cardiovascular disease mortality. Lancet. 2018;391:426\u20137.\n75 Gurfinkel EP, la Fuente de RL, Mendiz O, Mautner B. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation. 2002;105:2143\u20137.\n76 Gurfinkel EP, Leon de la Fuente R, Mendiz O, Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart J. 2004;25:25\u201331.\n77 Gurfinkel EP, la Fuente de RL. Two-year follow-up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry. Tex Heart Inst J. 2004;31:28\u201332.\n78 Skowronski DM, Chambers C, Sabaiduc S, De Serres G. A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014\u20132015 Season. Clinical Infectious Diseases. 2016;63:21\u201332.\n79 De Serres G, Skowronski DM, Ward BJ, et al. Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement. PLoS ONE 2017;12:e0163586.\n80 Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science 2020; eabb5793.\n81 Skowronski DM, Zou M, Clarke Q, et al. Influenza vaccine does not increase the risk of coronavirus or other non-influenza respiratory viruses: retrospective analysis from Canada, 2010-11 to 2016\u201317. Clin Infect Dis 2020; published online May 22. DOI:10.1093/cid/ciaa626.\n82 Cowling BJ, Fang VJ, Nishiura H, et al. Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clin Infect Dis. 2012;54:1778\u201383.\n83 Cohen J. Waning immunity. Science. 2019;364:224\u20137.\n84 Rambhia KJ, Rambhia MT. Early Bird Gets the Flu: What Should Be Done About Waning Intraseasonal Immunity Against Seasonal Influenza? Clinical Infectious Diseases. 2019;68:1235\u201340.\n86 Ihre Apotheke. Sicher und unkompliziert \u2013 Impfen direkt in der Apotheke. https://impfapotheke.ch (accessed July 10, 2020).\n87 Ohmit SE, Petrie JG, Malosh RE, Fry AM, Thompson MG, Monto AS. Influenza vaccine effectiveness in households with children during the 2012\u20132013 season: assessments of prior vaccination and serologic susceptibility. J Infect Dis. 2015;211:1519\u201328.\n87a Zelner J, Petrie JG, Trangucci R, Martin ET, Monto AS. Effects of Sequential Influenza A(H1N1)pdm09 Vaccination on Antibody Waning. J Infect Dis. 2019;220:12\u201319.\n88 Bartoszko JJ, McNamara IF, Aras OAZ, et al. Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis. Vaccine. 2018;36:3434\u201344.\n89 \u00d6rtqvist \u00c5, Brytting M, Leval A, Hergens M-P. Impact of repeated influenza vaccinations in persons over 65 years of age: A large population-based cohort study of severe influenza over six consecutive seasons, 2011/12\u20132016/17. Vaccine. 2018;36:5556\u201364.\n90 Casado I, Dom\u00ednguez \u00c1, Toledo D, et al. Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study. CMAJ. 2018;190:E3\u2013E12.\n91 Center for Disease Control and Prevention. Prevention and Control of Seasonal influneza with Vaccines: Recommendation of the Advisory Committee on Immunization Practices \u2013 United States, 2017\u201318 Influenza Season. Morbidity and Mortality Weekly Report 2017;66.\n92 Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2018;2:CD004879.\n93 Hodgson D, Baguelin M, van Leeuwen E, et al. Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis. Lancet Public Health. 2017;2:e74\u2013e81.\n94 Eidgen\u00f6ssisches Departement des Innern. Impfen gegen Grippe. Grippe: Impfen sch\u00fctzt.\n[https://www.impfengegengrippe.ch/de-ch/](https://www.impfengegengrippe.ch/de-ch/)\n(accessed July 10, 2020)\n95 Gaglani M, Vasudevan A, Raiyani C, et al. Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines against Influenza B in the United States, 2011\u20132012 to 2016\u20132017. Clin Infect Dis. 2020;103:e43.\n96 Kim Y-K, Song JY, Jang H, et al. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea. Pharmacoeconomics. 2018;36:1475\u201390.\n97 Mennini FS, Bini C, Marcellusi A, Rinaldi A, Franco E. Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy. Hum Vaccin Immunother. 2018;14:1867\u201373.\n98 Gostic KM, Bridge R, Brady S, Viboud C, Worobey M, Lloyd-Smith JO. Childhood immune imprinting to influenza A shapes birth year-specific risk during seasonal H1N1 and H3N2 epidemics. PLoS Pathog 2019; 15: e1008109.\n[https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1008109](https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1008109)\n99 Schaffner W, van Buynder P, McNeil S, Osterhaus ADME. Seasonal influenza immunisation: Strategies for older adults. Int J Clin Pract. 2018;72:e13249.\n100 Eidgen\u00f6ssisches Departement des Innern. Impfen gegen Grippe: Woraus besteht der Impfstoff? 2020; published online May 17.\n[https://www.impfengegengrippe.ch/de-ch/impfung/impfstoff.html](https://www.impfengegengrippe.ch/de-ch/impfung/impfstoffe.html)\n(accessed May 20, 2020).\n101 Bundesamt f\u00fcr Gesundheit. Acht Argumente f\u00fcr die Grippeimpfung der Fachpersonen im Gesundheitswesen. 2016.\n[https://www.impfengegengrippe.ch/files/downloads/FSH_120920_Argumentarium-Grippeimpfung-HCWs_DE_def.pdf](https://www.impfengegengrippe.ch/files/downloads/FSH_120920_Argumentarium-Grippeimpfung-HCWs_DE_def.pdf)\n(accessed May 20, 2020).\n102 Wilkinson K, Wei Y, Szwajcer A, et al. Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis. Vaccine. 2017;35:2775\u201380.\n103 Chang L-J, Meng Y, Janosczyk H, Landolfi V, Talbot HK, QHD00013 Study Group. Safety and immunogenicity of high-dose quadrivalent influenza vaccine in adults \u226565 years of age: A phase 3 randomized clinical trial. Vaccine. 2019;37:5825\u201334.\n104 Esposito S, Fling J, Chokephaibulkit K, et al. Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Seasonal Influenza Vaccine in Young Children at High Risk of Influenza-associated Complications: A Phase III, Randomized, Observer-blind, Multicenter Clinical Trial. The Pediatric Infectious Disease Journal 2020; Publish Ahead of Print. DOI:10.1097/INF.0000000000002727.\n105 Pillsbury AJ, Fathima P, Quinn HE, et al. Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older. JAMA Netw Open. 2020;3:e204079\u20139.\n106 Jang YH, Seong BL. The Quest for a Truly Universal Influenza Vaccine. Front Cell Infect Microbiol. 2019;9:344.\n107 Nachbagauer R, Palese P. Is a Universal Influenza Virus Vaccine Possible? Annu Rev Med. 2020;71:315\u201327.\n108 Krammer F. Emerging influenza viruses and the prospect of a universal influenza virus vaccine. Biotechnol J. 2015;10:690\u2013701.\n109 Bernstein DI, Guptill J, Naficy A, et al. Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial. The Lancet Infectious Diseases. 2020;20:80\u201391.\n110 Nachbagauer R, Krammer F. Universal influenza virus vaccines and therapeutic antibodies. Clin Microbiol Infect. 2017;23:222\u20138.\n111 Erbelding EJ, Post DJ, Stemmy EJ, et al. A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases. J Infect Dis. 2018;218:347\u201354.\n112 Nachbagauer R, Liu W-C, Choi A, et al. A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies. NPJ Vaccines. 2017;2:26\u201313.\n113 European Medicines Agency. Interim guidance on enhanced safety surveillance for seasonal influenza vaccines in the EU. 2014; published online April 10.\n[https://www.ema.europa.eu/en/interim-guidance-enhanced-safety-surveillance-seasonal-influenza-vaccines-eu](https://www.ema.europa.eu/en/interim-guidance-enhanced-safety-surveillance-seasonal-influenza-vaccines-eu)\n(accessed June 13, 2020).\n114 Choe YJ, Cho H, Kim SN, Bae G-R, Lee J-K. Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003\u20132010. Vaccine. 2011;29:7727\u201332.\n115 Rosenberg M, Sparks R, McMahon A, Iskander J, Campbell JD, Edwards KM. Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6\u201323 months of age. Vaccine. 2009;27:4278\u201383.\n116 Halsey NA, Talaat KR, Greenbaum A, et al. The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper. Vaccine. 2015;33(Suppl 5):F1\u2013F67.\n118 Vellozzi C, Iqbal S, Broder K. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence. Clin Infect Dis. 2014;58:1149\u201355.\n119 Sandhu SK, Hua W, MaCurdy TE, et al. Near real-time surveillance for Guillain-Barr\u00e9 syndrome after influenza vaccination among the Medicare population, 2010/11 to 2013/14. Vaccine. 2017;35:2986\u201392.\n120 Grave C, Boucheron P, Rudant J, et al. Seasonal influenza vaccine and Guillain-Barr\u00e9 syndrome: A self-controlled case series study. Neurology 2020;\n[doi: 10.1212/WNL.0000000000009180](https://n.neurology.org/content/94/20/e2168)\n.\n121 Shui IM, Rett MD, Weintraub E, et al. Guillain-Barr\u00e9 syndrome incidence in a large United States cohort (2000\u20132009). Neuroepidemiology. 2012;39:109\u201315.\n122 Kwong JC, Vasa PP, Campitelli MA, et al. Risk of Guillain-Barr\u00e9 syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. The Lancet Infectious Diseases. 2013;13:769\u201376.\n123 Baxter R, Bakshi N, Fireman B, et al. Lack of association of Guillain-Barr\u00e9 syndrome with vaccinations. Clin Infect Dis. 2013;57:197\u2013204.\n124 Mart\u00edn Arias LH, Sanz R, S\u00e1inz M, Trece\u00f1o C, Carvajal A. Guillain-Barr\u00e9 syndrome and influenza vaccines: A meta-analysis. Vaccine. 2015;33:3773\u20138.\n125 Zimmerman RK. Ethical analyses of institutional measures to increase health care worker influenza vaccination rates. Vaccine. 2013;31:6172\u20136.\n126 Konferenz der \u00e4rztlichen Direktorinnen und Direktoren DirMED sowie der Pflegedirektorinnen und Direktoren DirDSO der lateinischen Schweiz. Empfehlungen fu\u0308r die Pr\u00e4vention und die Versorgung der Infektionen durch das Grippevirus in den Spit\u00e4lern der lateinischen Schweiz.\n[https://public-health.ch/documents/1157/2018_Empfehlungen_8HtMGeK.pdf](https://public-health.ch/documents/1157/2018_Empfehlungen_8HtMGeK.pdf)\n(accessed May 8, 2020).\n127 Helms CM, Polgreen PM. Should influenza immunisation be mandatory for healthcare workers? Yes. BMJ. 2008;337:a2142\u20132.\n128 Williams CJ, Schweiger B, Diner G, et al. Seasonal influenza risk in hospital healthcare workers is more strongly associated with household than occupational exposures: results from a prospective cohort study in Berlin, Germany, 2006/07. BMC Infect Dis. 2010;10:8\u201311.\n129 Kuster SP, Coleman BL, Raboud J, et al. Risk factors for influenza among health care workers during 2009 pandemic, Toronto, Ontario, Canada. Emerging Infect Dis. 2013 19:606\u201315.\n130 Buckrell S, Coleman BL, McNeil SA, et al. Sources of viral respiratory infections in Canadian acute care hospital healthcare personnel. J Hosp Infect. 2020;104:513\u201321.\n131 Kuster SP, Shah PS, Coleman BL, et al. Incidence of influenza in healthy adults and healthcare workers: a systematic review and meta-analysis. PLoS ONE 2011;6:e26239.\n132 Thomas RE, Jefferson T, Lasserson TJ. Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. Cochrane Database Syst Rev 2016;355:CD005187.\n133 van Delden JJM, Ashcroft R, Dawson A, Marckmann G, Upshur R, Verweij MF. The ethics of mandatory vaccination against influenza for health care workers. Vaccine. 2008;26:5562\u20136.\n134 Bundesversammlung der Schweizerischen Eidgenossenschaft. Bundesgesetz \u00fcber die Bek\u00e4mpfung \u00fcbertragbarer Krankheiten des Menschen Artikel 22: Obligatorische Impfungen.\n[https://www.admin.ch/opc/de/classified-compilation/20071012/index.html#a22](https://www.admin.ch/opc/de/classified-compilation/20071012/index.html#a22)\n(accessed May 21, 2020).\n135 Eibach D, Casalegno J-S, Bouscambert M, et al. Routes of transmission during a nosocomial influenza A(H3N2) outbreak among geriatric patients and healthcare workers. J Hosp Infect. 2014;86:188\u201393.\n136 Goins WP, Talbot HK, Talbot TR. Health care-acquired viral respiratory diseases. Infect Dis Clin North Am. 2011;25:227\u201344.\n137 O\u2019Reilly F, Dolan GP, Nguyen-Van-Tam J, Noone P. Practical prevention of nosocomial influenza transmission, \u201ca hierarchical control\u201d issue. Occup Med (Lond) 2015;65:696\u2013700.\n138 Frenzel E, Chemaly RF, Ariza-Heredia E, et al. Association of increased influenza vaccination in health care workers with a reduction in nosocomial influenza infections in cancer patients. Am J Infect Control. 2016;44:1016\u201321.\n139 Pagani L, Thomas Y, Huttner B, et al. Transmission and effect of multiple clusters of seasonal influenza in a Swiss geriatric hospital. J Am Geriatr Soc. 2015;63:739\u201344.\n140 Perl TM, Talbot TR. Universal Influenza Vaccination Among Healthcare Personnel: Yes We Should. Open Forum Infect Dis. 2019;6:ofz096.\n141 Galanakis E, Jansen A, Lopalco PL, Giesecke J. Ethics of mandatory vaccination for healthcare workers. Euro Surveill. 2013;18:20627.\n142 Gostin LO, Salmon DA. The Dual Epidemics of COVID-19 and Influenza: Vaccine Acceptance, Coverage, and Mandates. JAMA 2020; published online June 11.\n[DOI:10.1001/jama.2020.10802](https://jamanetwork.com/journals/jama/fullarticle/2767284)\n.\n143 Isaacs D, Leask J. Should influenza immunisation be mandatory for healthcare workers? No. BMJ. 2008;337:a2140\u20130.\n144 Edmond MB. Mandatory Flu Vaccine for Healthcare Workers: Not Worthwhile. Open Forum Infect Dis. 2019;6:ofy214.\n145 Schweizer Berufsverband der Pflegefachfrauen und Pflegefachm\u00e4nner. Pflegefachpersonen und Grippeimpfung. Ethische Standpunkte 3. 2008; published online Oct.\n[https://www.sbk.ch/files/Shop/publikationen_de/1136/Grippe-d.pdf](https://www.sbk.ch/files/Shop/publikationen_de/1136/Grippe-d.pdf)\n(accessed June 13, 2020).\n146 Bundesamt f\u00fcr Gesundheit. Saisonale Grippe: Antworten auf h\u00e4ufige Fragen. 2018; published online Oct 22.\n[https://www.bag.admin.ch/dam/bag/de/dokumente/mt/infektionskrankheiten/grippe/fach-faq-grippe.pdf.download.pdf/grippe-faq-fach-de.pdf](https://www.infovac.ch/docs/public/influenza/faq-grippe-aw-faq-fach-de.pdf)\n(accessed June 17, 2020).\n147 Thurnherr U. Hat das Medizinpersonal eine moralische Pflicht, sich gegen Grippe impfen zu lassen? BAG Bulletin. 32 2003;5:63\u20135.\n148 Bundesamt f\u00fcr Gesundheit, Iten A, Siegrist C-A, Kaiser L. Grippepr\u00e4vention in den Spit\u00e4lern \u2013 eine grosse Herausforderung. BAG Bulletin; 2012;41:696\u2013698.\n149 Lau LLH, Cowling BJ, Fang VJ, et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis. 2010;201:1509\u201316.\n150 Voirin N, Payet C, Barrat A, et al. Combining high-resolution contact data with virological data to investigate influenza transmission in a tertiary care hospital. Infect Control Hosp Epidemiol. 2015;36:254\u201360.\n151 Chiu S, Black CL, Yue X, et al. Working with influenza-like illness: Presenteeism among US health care personnel during the 2014\u20132015 influenza season. Am J Infect Control. 2017;45:1254\u20138.\n152 Murti M, Otterstatter M, Orth A, et al. Measuring the impact of a mandatory province-wide vaccinate-or-mask policy on healthcare worker absenteeism in British Columbia, Canada. Vaccine. 2019;37:4008\u201314.\n153 Kelly SG, Metzger K, Bolon MK, et al. Respiratory syncytial virus outbreak on an adult stem cell transplant unit. Am J Infect Control. 2016;44:1022\u20136.\n154 Kumar S, Grefenstette JJ, Galloway D, Albert SM, Burke DS. Policies to reduce influenza in the workplace: impact assessments using an agent-based model. Am J Public Health. 2013;103:1406\u201311.\n155 Jackson LA, et al. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006;35(2):337\u201344\n156 McElhaney JE, McNeil SA. Test-Negative Design: The Importance of Laboratory-Confirmed Illness in Estimating the Effectiveness of Influenza Vaccine in Older Adults. J Infect Dis. 2017;216(4):399\u2013401.\n157 W Paul Glezen, Lone Simonsen, Commentary: Benefits of influenza vaccine in US elderly \u2013 new studies raise questions. International Journal of Epidemiology, 2006;35(2):352\u20133.\n[https://doi.org/10.1093/ije/dyi293](https://doi.org/10.1093/ije/dyi293)\n158 Dugan HL, Henry C, Wilson PC. Aging and influenza vaccine-induced immunity. Cell Immunol. 2020 Feb;348:103998.\n[doi: 10.1016/j.cellimm.2019.103998](https://www.sciencedirect.com/science/article/abs/pii/S0008874919304125)\n. Epub 2019 Oct 31. PMID: 31733824.\n159 Bundesamt f\u00fcr Gesundheit. Bericht zur Grippesaison 2018/19. BAG Bulletin 29 2019; 9\u201321.\n[https://www.infovac.ch/docs/public/influenza/bericht-zur-grippesaison-2018\u201319-.pdf](https://www.infovac.ch/docs/public/influenza/bericht-zur-grippesaison-2018-19-.pdf)\n160 Josine van Beek, Reinier H Veenhoven, Jacob P Bruin, Ren\u00e9e A J van Boxtel, Marit M A de Lange, Adam Meijer, Elisabeth A M Sanders, Nynke Y Rots, Willem Luytjes. Influenza-like Illness Incidence Is Not Reduced by Influenza Vaccination in a Cohort of Older Adults, Despite Effectively Reducing Laboratory-Confirmed Influenza Virus Infections. The Journal of Infectious Diseases, 15 2017;216(4):415\u201324.\n[https://doi.org/10.1093/infdis/jix268](https://doi.org/10.1093/infdis/jix268)\n161 Souty C, Masse S, Valette M, Behillil S, Bonmarin I, Pino C, Turbelin C, Capai L, Vilcu AM, Lina B, van der Werf S, Blanchon T, Falchi A, Hanslik T. Baseline characteristics and clinical symptoms related to respiratory viruses identified among patients presenting with influenza-like illness in primary care. Clin Microbiol Infect. 2019;25(9):1147\u20131153.\n[doi: 10.1016/j.cmi.2019.01.014](https://pubmed.ncbi.nlm.nih.gov/30703528/)\n. Epub 2019 Jan 29. PMID: 30703528; PMCID: PMC7172742.\n162 Wolf, GG. Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017\u20132018 influenza season. Vaccine. 2020;38(2):350\u2013354.\n163 P\u00e4diatrie Schweiz. Grippeimpfung bei Kindern und Jugendlichen. 2020 [cited 2020 03.11.2020]; Available from:\n[https://www.paediatrieschweiz.ch/news/grippeimpfung/](https://www.paediatrieschweiz.ch/news/grippeimpfung/)\n164 Gostic KM, et al. Childhood immune imprinting to influenza A shapes birth year-specific risk during seasonal H1N1 and H3N2 epidemics. PLoS Pathog. 2019;15(12):e1008109.\n165 Ip DKM, et al. The Dynamic Relationship Between Clinical Symptomatology and Viral Shedding in Naturally Acquired Seasonal and Pandemic Influenza Virus Infections. Clin Infect Dis. 2016;62(4):431\u20137.\n166 Kwong JC. Editorial Commentary: Symptoms and Viral Shedding in Naturally Acquired Influenza Infections. Clin Infect Dis. 2016;62(4):438\u20139.\n167 Ip DK, et al. Viral Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Influenza Virus Infections in the Community. Clin Infect Dis. 2017;64(6):736\u201342.\nDie wichtigsten Referenzen\n\u2013 Osterholm MT, Kelley NS, Manske JM. The Compelling need for game-changing influneza vaccines. Center for Infectious Disease Research and Policy. 2012;\n[https://www.cidrap.umn.edu/compelling-need-game-changing-influenza-vaccines](https://www.cidrap.umn.edu/compelling-need-game-changing-influenza-vaccines)\n\u2013 Demicheli V, Jefferson T, Ferroni E, Rivetti A, Di Pietrantonj C. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2018; 2: CD001269.\n\u2013 Demicheli V, Jefferson T, Di Pietrantonj C, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2018; 2: CD004876.\n\u2013 Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2018; 2: CD004879.", "language": null, "image": null, "pagetype": "article", "links": ["https://www.swisshealthweb.ch/de/newsfeed/", "https://phc.swisshealthweb.ch/de/", "#collapseSearch", "/de/article/doi/phc-d.2021.10341/", "/fr/article/doi/phc-f.2021.10341/", "https://www.swisshealthweb.ch/de/newsfeed/", "https://phc.swisshealthweb.ch/de/", "/de/", "/de/aktuelle-ausgabe/", "/de/archiv/", "/de/publizieren/", "/de/ueber-phc/", "https://www.swisshealthweb.ch/de/zeitschriften/", "https://shop.emh.ch/", "https://www.swisshealthweb.ch/de/encyclomed/", "https://events.emh.ch", "https://phc.swisshealthweb.ch/de/article/?tx_cs2services_teaser%5Baction%5D=serviceLinkHandler&tx_cs2services_teaser%5Bcontroller%5D=Services&tx_cs2services_teaser%5Bservice%5D=9&type=96529&cHash=957c22557b087f72957914479c8387b5", "https://jobs.saez.ch/de", "https://market.swisshealthweb.ch/de/", null, "tel:+410614678555", "#", "https://www.swisshealthweb.ch/de/newsfeed/", "/de/article/doi/phc-d.2021.10341/", "/fr/article/doi/phc-f.2021.10341/", "https://events.emh.ch/", "https://jobs.saez.ch/de", "https://market.swisshealthweb.ch/de/", "https://shop.emh.ch/", null, "javascript:void(0)", "https://phc.swisshealthweb.ch/fileadmin/assets/PHC/2021/phc-d.2021.10341/phc-d-2021-10341.pdf", "#otherInfos", "/de/archiv/ausgabe/issue-doi/phc.2021.02/", "https://doi.org/10.4414/phc-d.2021.10341", "javascript:void(0)", "https://phc.swisshealthweb.ch/fileadmin/assets/PHC/2021/phc-d.2021.10341/phc-d-2021-10341.pdf", "http://www.nfp74.ch/de/projekte/ambulante-versorgung/projekt-tarr", "https://www.infovac.ch/de/", "https://primary-hospital-care.ch/article/doi/phc-d.2020.10323", "https://www.bag.admin.ch/bag/de/home/das-bag/publikationen/broschueren/publikationen-uebertragbare-krankheiten/strategie-grips.html", "https://www.bag.admin.ch/dam/bag/de/dokumente/e-f/evalber-mt/2012-evaluation-saisonale-grippe-2008-2012-executive-summary.pdf.download.pdf/2011-excsum-eval-komm-saisonale-grippe-d.pdf", "https://www.cidrap.umn.edu/compelling-need-game-changing-influenza-vaccines", "https://www.infovac.ch/docs/public/influenza/faq-saisonale-grippe-de.pdf", "https://www.infovac.ch/de/impfunge/nach-krankheiten-geordnet/grippe", "https://www.bag.admin.ch/dam/bag/de/dokumente/mt/i-und-b/richtlinien-empfehlungen/empfehlungen-spezifische-erreger-krankheiten/grippe/grippe-empfehlungen-grippeimpfung.pdf.download.pdf/emp-r-e-2011-grippeimpfung.pdf", "https://www.cdc.gov/flu/vaccines-work/vaccineeffect.htm", "https://www.bag.admin.ch/bag/de/home/gesund-leben/gesundheitsfoerderung-und-praevention/impfungen-prophylaxe/schweizerischer-impfplan.html", "https://www.medix.ch/media/factsheet_impfungen_2018.pdf", "https://pharma.unibas.ch/fileadmin/user_upload/pharma/Research_groups/Pharmaceutical_Care/Bilder/Other/Flu_Vaccination_Campaign/Grippeimpfaktion_-_Schlussberichte/Schlussbericht_Grippeimpfaktion_2004.pdf", "https://www.impfengegengrippe.ch/de-ch/", "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1008109", "https://www.impfengegengrippe.ch/de-ch/impfung/impfstoffe.html", "https://www.impfengegengrippe.ch/files/downloads/FSH_120920_Argumentarium-Grippeimpfung-HCWs_DE_def.pdf", "https://www.ema.europa.eu/en/interim-guidance-enhanced-safety-surveillance-seasonal-influenza-vaccines-eu", "https://www.bag.admin.ch/bag/de/home/krankheiten/krankheiten-im-ueberblick/grippe.html", "https://n.neurology.org/content/94/20/e2168", "https://public-health.ch/documents/1157/2018_Empfehlungen_8HtMGeK.pdf", "https://www.admin.ch/opc/de/classified-compilation/20071012/index.html#a22", "https://jamanetwork.com/journals/jama/fullarticle/2767284", "https://www.sbk.ch/files/Shop/publikationen_de/1136/Grippe-d.pdf", "https://www.infovac.ch/docs/public/influenza/faq-grippe-aw-faq-fach-de.pdf", "https://doi.org/10.1093/ije/dyi293", "https://www.sciencedirect.com/science/article/abs/pii/S0008874919304125", "https://www.infovac.ch/docs/public/influenza/bericht-zur-grippesaison-2018-19-.pdf", "https://doi.org/10.1093/infdis/jix268", "https://pubmed.ncbi.nlm.nih.gov/30703528/", "https://www.paediatrieschweiz.ch/news/grippeimpfung/", "https://www.cidrap.umn.edu/compelling-need-game-changing-influenza-vaccines", "https://emh.ch/en/emh/rights-and-licences/", "#top", null, null, "tel:+410614678555", "#", "https://www.swisshealthweb.ch/de/newsfeed/", "https://www.swisshealthweb.ch/de/informationen-und-services/qualitaetssicherung/", "https://www.swisshealthweb.ch/de/informationen-und-services/publizistische-leitlinien/", "https://www.swisshealthweb.ch/de/informationen-und-services/copyright/", "https://www.swisshealthweb.ch/de/informationen-und-services/newsletter/", "https://www.swisshealthweb.ch/de/verlag/ueber-emh/", "https://www.swisshealthweb.ch/de/verlag/inserieren/", "https://www.swisshealthweb.ch/de/verlag/jobs/", "https://www.swisshealthweb.ch/de/partner/", "https://www.swisshealthweb.ch/de/verlag/hilfe-und-kontakt/", "https://www.swisshealthweb.ch/de/agb/", "https://www.swisshealthweb.ch/de/verlag/impressum/", "https://www.swisshealthweb.ch/de/verlag/datenschutz/", "https://www.swisshealthweb.ch/de/verlag/disclaimer/", "javascript:void()"]}